Form 4: Merit Medical Systems Director Gunderson Receives Stock Grant
SEC Form 4 Filing
Director Thomas James Gunderson of Merit Medical Systems reports the acquisition of 2,152 restricted stock units and updates to existing stock options.
Summary
- Thomas James Gunderson, a director at Merit Medical Systems, filed a Form 4 detailing changes in beneficial ownership.
- On May 15, 2025, Gunderson acquired 2,152 restricted stock units (RSUs) under the company's 2018 Long-Term Incentive Plan.
- These RSUs will vest on May 15, 2026, contingent upon continued service to the issuer.
- Gunderson also holds non-qualified stock options to buy 13,750 shares at $52.17, which became exercisable in installments starting May 24, 2020.
- Additionally, he holds options to buy 7,500 shares at $52.17, exercisable in installments from May 31, 2020.
- Following the reported transaction, Gunderson beneficially owns 36,034 shares of common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating standard compensation practices. There are no overtly positive or negative implications.
Positives
- The grant of RSUs to a director aligns their interests with the long-term performance of the company.
- Gunderson's continued holding of stock options indicates confidence in the company's future prospects.
Risks
- The vesting of RSUs is contingent upon continued service, creating a potential risk if Gunderson were to leave the company before the vesting date.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates ongoing equity-based compensation practices at Merit Medical Systems.
Comparison to Industry Standards
- Equity grants are a common form of compensation for directors in publicly traded companies, aligning their interests with shareholders.
- The vesting schedule and terms of the stock options appear standard for executive compensation packages.
Stakeholder Impact
- The equity grant aligns the director's interests with shareholders, potentially encouraging decisions that benefit the company's long-term value.
Key Dates
| Date | Description |
|---|---|
| 05/24/2020 | Start date for exercisable installments of non-qualified stock options (13,750 shares). |
| 05/31/2020 | Start date for exercisable installments of non-qualified stock options (7,500 shares). |
| 05/15/2025 | Date of transaction: Acquisition of 2,152 restricted stock units (RSUs). |
| 05/19/2025 | Date of Form 4 filing. |
| 05/15/2026 | Vesting date for the 2,152 restricted stock units (RSUs). |
| 05/24/2026 | Expiration date for non-qualified stock options (13,750 shares). |
| 05/31/2026 | Expiration date for non-qualified stock options (7,500 shares). |
Keywords
Form 4, beneficial ownership, restricted stock units, stock options, MMSI, Merit Medical Systems, Gunderson, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.